I.B.T. Joosten

Bovenkerk, D. S. H., La Fontaine, L. A., Hermans, A. N. L., van Kuijk, S. M. J., Joosten, I. B. T., Faber, C. G., Lankveld, T. A. R., den Uijl, D., Vernooy, K., Hendriks, J. M., Linz, D., & Hermans, B. J. M. (2026). Annual assessment of ECG intervals in patients with myotonic dystrophy type 1 using a mobile 6-lead ECG device: TeleCheck-DM1. IJC Heart and Vasculature, 66, Article 101996. https://doi.org/10.1016/j.ijcha.2026.101996

Aarts, W. J. A., van Veen, B. P. A. P., Fuchs, C. J., Cote, C., Hover, L., van Loon, L. J. C., Keszthelyi, D., Mul, K., Faber, C. G., & Joosten, I. B. T. (2026). Energy expenditure and the accuracy of predictive equations in myotonic dystrophy type 1. Journal of neuromuscular diseases. Advance online publication. https://doi.org/10.1177/22143602261470256

Bovenkerk, D. S. H., Janssen, C. E. W., Van den Heuvel, F. M. A., Joosten, I. B. T., Den Uijl, D., Van Engelen, B. G. M., Van Kuijk, S. M. J., Nijveldt, R., Evertz, R., Faber, C. G., Vernooy, K., & Bijvoet, G. P. (2025). Evaluation of echocardiography monitoring in myotonic dystrophy type 1 patients. Frontiers in Cardiovascular Medicine, 12, Article 1574885. https://doi.org/10.3389/fcvm.2025.1574885

Vosse, B. A. H., Horlings, C. G. C., Joosten, I. B. T., Cobben, N. A. M., van Kuijk, S. M. J., Wijkstra, P. J., & Faber, C. G. (2023). Role of respiratory characteristics in treatment adherence with noninvasive home mechanical ventilation in myotonic dystrophy type 1, a retrospective study. Neuromuscular Disorders, 33(9), 57-62. https://doi.org/10.1016/j.nmd.2023.08.004

Joosten, I. B. T., Janssen, C. E. W., Horlings, C. G. C., den Uijl, D., Evertz, R., van Engelen, B. G. M., Faber, C. G., & Vernooy, K. (2023). An evaluation of 24 h Holter monitoring in patients with myotonic dystrophy type 1. EP Europace, 25(1), 156-163. https://doi.org/10.1093/europace/euac104

Joosten, I. B. T., Horlings, C. G. C., Vosse, B. A. H., Wagner, A., Bovenkerk, D. S. H., Evertz, R., Vernooy, K., van Engelen, B. G. M., & Faber, C. G. (2023). Myotonic dystrophy type 1: a comparison between the adult- and late-onset subtype. Muscle & Nerve, 67(2), 130-137. https://doi.org/10.1002/mus.27766

Joosten, I. B. T., Fuchs, C. J., Beelen, M., Plasqui, G., Van Loon, L. J. C., & Faber, C. G. (2023). Energy Expenditure, Body Composition, and Skeletal Muscle Oxidative Capacity in Patients with Myotonic Dystrophy Type 1. Journal of neuromuscular diseases, 10(4), 701-712. https://doi.org/10.3233/JND-230036

Sopacua, M., Gorissen-Brouwers, C. M. L., de Greef, B. T. A., Joosten, I. B. T., Faber, C. G., Merkies, I. S. J., & Hoeijmakers, J. G. J. (2022). The applicability of the digit wrinkle scan to quantify sympathetic nerve function. Clinical Neurophysiology Practice, 7, 115-119. https://doi.org/10.1016/j.cnp.2022.03.005

Joosten, I. B. T., van Lohuizen, R., den Uijl, D. W., Evertz, R., de Greef, B. T. A., van Engelen, B. G. M., Faber, C. G., & Vernooy, K. (2021). Electrocardiographic predictors of infrahissian conduction disturbances in myotonic dystrophy type 1. EP Europace, 23(2), 298-304. https://doi.org/10.1093/europace/euaa256